CONTENTS 211 Ongoing Trials in More than 10 Therapeutic Areas 106 Sponsors from 13 Countries Have Initiated These 211 Ongoing Trials 68 % of On Going Trials with At Least One Location in the USA 72 % of On Going Trials with At Least One Location in Europe AAV-Based Vectors [...]
BioNTech, CureVac, Moderna Therapeutics, Translate Bio…. These four biotech are the main state-of-the-art companies at the forefront in mRNA science. All of them are now developing mRNA-based vaccine candidates against SARS-CoV-2 and have reached the clinical stage. These programs could lead to short-term boosts for these companies’s shares. However, addressing epidemics is still a risky business. So far, it isn’t the [...]
Mapping
BREAKING NEWS: AAV-Based Gene Therapy Products: Ongoing Clinical Trials. New Report (June 2020)
OctopusyX BioConsulting (Olivier REVELANT, @octopusyx2), a member of Eurobiomed, and BioPharmAnalyses (Anne-Lise BERTHIER, @anneliseberthie) are proud to announce the launch of their new report entitled "AAV-based Gene Therapy Products: Ongoing Clinical Trials". This >200 pages report provides a unique exhaustive overview of 116 ongoing trials for the treatment of 40 diseases (as of June 2020). More thant 80 AAV based products described.
Wishing to identify hot research topics in this highly competitive field ?
Looking for an update on the clinical portfolio ?
Needing insights to assist you in your decision-making or to identify the most advanced companies in the field ?
Searching for new candidates to in-license ?
● 205 pages detailing 116 clinical trials for the treatment of 40 diseases
● 49 companies and academic institutions developing more than 80 AAVbased gene therapy products in a wide range of therapeutic areas (Cardiovascular Diseases, Hematological Diseases, Hepatic Diseases, Infectious Diseases, inherited Metabolic Diseases, Lysosomal Diseases, Neurological Diseases, Neuromuscular Diseases and Ophthalmological Diseases)
Want to have a look at this report ? Click to download sample pages (http://biopharmanalyses.fr/wp-content/uploads/2020/06/sample-pages.pdf)
Order Form (http://biopharmanalyses.fr/wp-content/uploads/2020/06/order-form.pdf)
RNA science is now translated into new therapies… Six RNA-based products are now approved More than one hundred candidates have reached the clinical stage… “BRIEFING ON RNA TRIALS” provides you an accurate overview to explore the latest trials in this dynamic and rapidly evolving field FOUR REASONS TO BUY: Wishing to identify hot research topics in [...]
Briefing
BioPharmAnalyses and Octopusyx BioConsulting are happy to announce the release of the second issue of their “BRIEFING ON CART-T CELLS TRIALS” At least 5 reasons to buy “BRIEFING ON CART-T CELLS TRIALS” More than 140 new clinical trials registered between 01/01/2018 and 12/01/2019 For each clinical trial mentioned, a novel format enriched by relevant contextualisation [...]